South Miami Neurology

305-665-6501 Patient Portal

donanemab

Alzheimer’s Disease Symptoms, Causes, and Treatments

Alzheimer's Disease /

Alzheimer’s disease is a progressive neurological disorder that affects millions of people worldwide, leading to memory loss, cognitive decline, and significant disruptions in daily life. It is the most common form of dementia, a general term for conditions characterized by a decline in cognitive abilities severe enough to interfere with daily activities. Despite its prevalence,

Alzheimer’s Disease Symptoms, Causes, and Treatments Read More »

Donanemab Slowed Cognitive Decline in Lilly’s Phase 3 Alzheimer’s Study

Alzheimer's Disease /

Last week Eli Lilly and Company announced that nearly half of the participants on their early Alzheimer’s drug donanemab had no clinical progression at 1 year. The study showed donanemab treatment slowed clinical decline by 35% compared to placebo and resulted in 40% less decline in the ability to perform activities of daily living. Based

Donanemab Slowed Cognitive Decline in Lilly’s Phase 3 Alzheimer’s Study Read More »

Scroll to Top